Aclaris Therapeutics to Participate in Two June Healthcare Conferences#Aclaris #Therapeutics #Participate #June #Healthcare #Conferences
Tag: Therapeutics
TG Therapeutics: Estimates Could Soon Be Raised Again
TG Therapeutics: Estimates Could Soon Be Raised Again #Therapeutics #Estimates #Raised
Candel Therapeutics: CAN-2409's Promising Progress Deserves An Upgrade
Candel Therapeutics: CAN-2409's Promising Progress Deserves An Upgrade #Candel #Therapeutics #CAN2409039s #Promising #Progress #Deserves #Upgrade
Cidara Therapeutics: All Stars Aligning In Favor Of CD388
Cidara Therapeutics: All Stars Aligning In Favor Of CD388 #Cidara #Therapeutics #Stars #Aligning #Favor #CD388
Atossa Therapeutics CEO Steven Quay buys $9,886 in common stock
Atossa Therapeutics CEO Steven Quay buys $9,886 in common stock#Atossa #Therapeutics #CEO #Steven #Quay #buys #common…
Protagenic Therapeutics Skyrockets on Merger with Phytanix Bio: A Biotech Powerhouse in the Making?
Holy cow, folks, the market’s on fire today, and Protagenic Therapeutics (Nasdaq: PTIX) is leading the…
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Soci
Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial…
Tenaya therapeutics SVP Higa Tomohiro sells $615 in stock
Tenaya therapeutics SVP Higa Tomohiro sells $615 in stock#Tenaya #therapeutics #SVP #Higa #Tomohiro #sells #stock
Abeona Therapeutics Inc. (ABEO) Q1 2025 Earnings Call Transcript
Abeona Therapeutics Inc. (ABEO) Q1 2025 Earnings Call Transcript #Abeona #Therapeutics #ABEO #Earnings #Call #Transcript
Spur Therapeutics reports progress in gene therapy trials
Spur Therapeutics reports progress in gene therapy trials#Spur #Therapeutics #reports #progress #gene #therapy #trials
Pasithea Therapeutics CEO sells shares worth $792
Pasithea Therapeutics CEO sells shares worth $792#Pasithea #Therapeutics #CEO #sells #shares #worth
Plus Therapeutics reports progress in CNS cancer therapy
Plus Therapeutics reports progress in CNS cancer therapy#Therapeutics #reports #progress #CNS #cancer #therapy
Y-mAbs Therapeutics, Inc. (YMAB) Q1 2025 Earnings Call Transcript
Y-mAbs Therapeutics, Inc. (YMAB) Q1 2025 Earnings Call Transcript #YmAbs #Therapeutics #YMAB #Earnings #Call #Transcript
Sangamo Therapeutics, Inc. 2025 Q1 – Results – Earnings Call Presentation
Sangamo Therapeutics, Inc. 2025 Q1 – Results – Earnings Call Presentation #Sangamo #Therapeutics #Results #Earnings #Call…
Karyopharm Therapeutics Inc. 2025 Q1 – Results – Earnings Call Presentation
Karyopharm Therapeutics Inc. 2025 Q1 – Results – Earnings Call Presentation #Karyopharm #Therapeutics #Results #Earnings #Call…
CytomX Therapeutics, Inc. (CTMX) CX-2051 Phase 1 Interim Clinical Data Call (Transcript)
CytomX Therapeutics, Inc. (CTMX) CX-2051 Phase 1 Interim Clinical Data Call (Transcript) #CytomX #Therapeutics #CTMX #CX2051…
Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Congress 2025
Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster…
Apogee Therapeutics chief medical officer sells shares totaling $97,418
Apogee Therapeutics chief medical officer sells shares totaling $97,418#Apogee #Therapeutics #chief #medical #officer #sells #shares #totaling
LENZ Therapeutics inks deal with Lotus for eye treatment
LENZ Therapeutics inks deal with Lotus for eye treatment#LENZ #Therapeutics #inks #deal #Lotus #eye #treatment
Corcept Therapeutics chief development officer sells $524,652 in stock
Corcept Therapeutics chief development officer sells $524,652 in stock#Corcept #Therapeutics #chief #development #officer #sells #stock
Coya Therapeutics to Participate in Two Upcoming Conferences in May 2025
Coya Therapeutics to Participate in Two Upcoming Conferences in May 2025#Coya #Therapeutics #Participate #Upcoming #Conferences
Corcept Therapeutics Incorporated (CORT) Q1 2025 Earnings Call Transcript
Corcept Therapeutics Incorporated (CORT) Q1 2025 Earnings Call Transcript #Corcept #Therapeutics #Incorporated #CORT #Earnings #Call #Transcript